Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInsig Ai Plc Regulatory News (INSG)

Share Price Information for Insig Ai Plc (INSG)

Share Price is delayed by 15 minutes
Get Live Data
14.00    0.00 (0.00%)
Bid:
13.50
Ask:
14.50
Spread: 1.00 (7.407%)
Market Cap: £17.86m
INSG Live PriceLast checked at - London Stock Exchange

Intraday Insig Ai Plc Share Chart

Colm McVeigh appointment to the Board

10 Dec 2021 07:00

RNS Number : 1950V
Insig AI Plc
10 December 2021
 

10 December 2021

Insig AI plc

("Insig AI", the "Company" or the "Group")

 

Colm McVeigh appointment to the Board

 

Insig AI is pleased to announce that Colm McVeigh, Chief Commercial Officer, has been appointed to the Company's board of directors, further to the announcement made on 10 November 2021.

Colm has held senior commercial roles in the software and telecoms sectors with a strong track record of driving growth and business transformation. From 2016 until September 2021, Colm was the Chief Commercial Officer of BT One Phone, the mobile Cloud SaaS joint venture. He led the commercial turnaround, which resulted in a high multiple EBITDA minority interest sale valued at £320 million. Colm spent more than ten years at BT, having been part of its core BT Business due diligence team for BT Group's acquisition of EE Mobile and then led the commercial Integration of EE into BT Business.

Prior to BT Group, Colm spent seven years at Vodafone Group, initially as Enterprise Director and later as Global Director M2M (Mobile to Mobile) Smart Services, where he established the Internet of Things as a global business model. Before then, Colm held senior commercial roles at Oracle Corporation.

Steve Cracknell, Insig AI plc CEO commented: "Colm has made an immediate and positive impact in spearheading our commercial strategy. We are delighted with the progress he is already making."

In accordance with Schedule 2(g) of the AIM Rules, Colm McVeigh (aged 57) does not currently hold any directorships or partnerships, nor has he held any within the past five years.

Colm McVeigh does not hold any ordinary shares in Insig AI plc but has been granted options over 2 million ordinary shares under the Company's existing share option scheme and has been awarded warrants over 1.5 million ordinary shares at 100p a share, 1.5 million ordinary shares at 150p a share, 1.5 million ordinary shares at 200p a share and 1.5 million ordinary shares at 250p a share.

For further information, please visit www.insg.ai, or contact:

 

Insig AI plc

Steve Cracknell, CEO

 

Via SEC Newgate

Zeus Capital Limited (Nominated Adviser & Broker)

David Foreman / James Hornigold / Daniel Philips

 

+44 (0) 203 829 5000

SEC Newgate (Financial PR)

Robin Tozer / Tom Carnegie / Richard Bicknell 

 

+44 (0) 7540 106 366

insigai@secnewgate.co.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEAXANEDLFFFA
Date   Source Headline
1st Jun 20267:00 amRNSEquity subscription raising £0.2m and TVR
30th Apr 20267:00 amRNSNon-executive Directors’ Remuneration in Shares
22nd Apr 20267:00 amRNSEquity Subscription, TVR and PDMR Dealing
20th Apr 20267:00 amRNS-RCentral Bank MCP server in action
13th Apr 20267:00 amRNS-RLaunch of Central Bank Model Context Protocol
7th Apr 20267:01 amRNSHolding(s) in Company
7th Apr 20267:00 amRNSPDMR Dealings
1st Apr 20267:00 amRNSTrading update and potential NASDAQ listing
3rd Mar 20267:00 amRNSInsig AI contract win and revenue share agreement
28th Jan 20267:00 amRNSGrant of Share Options
28th Jan 20267:00 amRNSPDMR Dealing
27th Jan 20267:00 amRNSPDMR Dealing
11th Dec 20257:00 amRNSDirector Dealings
9th Dec 20257:00 amRNSInterim results
10th Nov 20257:00 amRNSNew contract with global advisory firm
29th Oct 20257:00 amRNS-RNew client win: new vertical market breakthrough
27th Oct 20257:00 amRNS-RMelloLondon Investor Event
16th Oct 20253:51 pmRNSResult of AGM
16th Oct 20257:00 amRNSTrading update & extended CLNs and warrant terms
8th Oct 202511:43 amRNSEquity fundraise
7th Oct 20257:00 amRNSEquity fundraise
1st Oct 20257:00 amRNSAppointment of Digital Asset Adviser
22nd Sep 20257:00 amRNSSubscription, Director Dealing & TVR
19th Sep 20257:00 amRNSFinal Results, Posting of AR&A and Notice of AGM
30th Jul 20257:00 amRNS-RLaunch of New Website and Corporate Brand Update
24th Jul 20257:00 amRNSDirector Dealing and Total Voting Rights
3rd Jul 20257:00 amRNSAppointment - Strategic & Asset Allocation Adviser
24th Jun 20257:05 amRNS-RAppointment of Business Development Director
24th Jun 20257:00 amRNSEquity Funding, Subscription, TVR & PDMR Dealing
6th Jun 20257:00 amRNSPDMR Dealings
20th May 20257:00 amRNS-RNew client win and additional sales prospects
12th May 20257:00 amRNS-RMello2025 Investor Event
8th May 20257:00 amRNS-RStrategic client win and new GIE product launch
6th May 20258:00 amRNS-RInsig AI & Falcon Windsor publish research re FTSE
29th Apr 20257:00 amRNSTrading Update and New Client Win
15th Apr 20257:00 amRNSPDMR Dealings
27th Mar 20257:00 amRNSPDMR Dealings
26th Mar 20257:00 amRNSPDMR Dealings
25th Mar 20257:00 amRNSPDMR Dealings
24th Mar 20257:03 amRNSTransfer of Share Options
24th Mar 20257:00 amRNSTrading Update, Equity Subscription, Funding & TVR
13th Mar 20257:00 amRNSNotice of Investor Presentation
3rd Mar 20259:21 amRNSReplacement: Change of website address
3rd Mar 20257:00 amRNSChange of website address
17th Feb 20257:00 amRNSNew Client Win and Revenue Share Partnership
19th Dec 20247:00 amRNSInterim Results
22nd Nov 20247:00 amRNSNew business win
11th Oct 20247:00 amRNSDirector Dealing
2nd Oct 202411:14 amRNSPDMR Dealing
30th Sep 20242:41 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.